| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 07/10/2003 | US20030129678 Methods, pharmaceutical formulations and kits for identification of subjects at risk for cancer |
| 07/10/2003 | US20030129676 Methods and reagents for the rapid and efficient isolation of circulating cancer cells |
| 07/10/2003 | US20030129672 Method for identifying metalloenzyme inhibitors |
| 07/10/2003 | US20030129671 Design and construction of small, typically single-use, modules capable of receiving and rapidly conducting a predetermined assay protocol on a fluid sample. |
| 07/10/2003 | US20030129667 Measurement of the altered expression of a marker protein, which is the prion protein PrP-sen |
| 07/10/2003 | US20030129665 Performing a cluster designation count with an optical disc and disc drive; assays conducted on cell populations derived from blood, hematological leukemias, lymphomas, bone marrow, and stem cells |
| 07/10/2003 | US20030129663 Methods and compositions for modulating oxidized ldl transport |
| 07/10/2003 | US20030129659 Machine-based method for managing library information, comprising: storing information about associations between members and assay information, and evaluating the stored information to identify a subset of the individual members |
| 07/10/2003 | US20030129658 Novel protease |
| 07/10/2003 | US20030129655 Nucleic acids encoding GTPase activating proteins |
| 07/10/2003 | US20030129653 Treating aberrant cell growth, endocrine conditions, neurological conditions, and diseases or disorders related to the pituitary gland, colon, breast, lungs, and prostate |
| 07/10/2003 | US20030129645 Can be used as models for the development of human therapeutic targets, aid in the identification of therapeutic proteins, and serve as targets for the development of human therapeutic agents that modulate kinase activity |
| 07/10/2003 | US20030129644 Used in gene therapy |
| 07/10/2003 | US20030129641 Detecting a nucleic acid specific to the biospecies by hybridizing oligonucleotide synthesized based on a sequence specific to the biospecies in a DNA sequence corresponding to a ribosomal RNA gene or a cytochrome-related gene |
| 07/10/2003 | US20030129640 Target detection method, reagent and method for detecting SNP of DNA nucleotide sequences |
| 07/10/2003 | US20030129638 Reagents for antagonizing the protein-protein interaction between Raf-1 and apoptosis signal-regulating kinase and uses therefor |
| 07/10/2003 | US20030129637 Quantification by inhibition of amplification |
| 07/10/2003 | US20030129634 General screening method for ligand-protein interactions |
| 07/10/2003 | US20030129632 Method for detecting product of nucleic acid synthesizing reaction |
| 07/10/2003 | US20030129631 Three of three sets of RT-PCR-amplified transcripts from prostatic adenocarcinomas display multiple cancer-associated coding sequence changes; normal pp32 exerts antineoplastic effects through suppression of transformation. |
| 07/10/2003 | US20030129630 Genetic markers associated with desirable and undesirable traits in horses, methods of identifying and using such markers |
| 07/10/2003 | US20030129629 Methods and compositions for the identification, assessment, prevention, and therapy of human cancers |
| 07/10/2003 | US20030129628 Anti-idiotypic antibody and its use in diagnosis and therapy in HIV-related disease |
| 07/10/2003 | US20030129627 Multidentate arrays |
| 07/10/2003 | US20030129626 Methods, kits and compositions pertaining to the suppression of detectable probe binding to randomly distributed repeat sequences in genomic nucleic acid |
| 07/10/2003 | US20030129625 Methods of using 5433, a human calcium channel family member |
| 07/10/2003 | US20030129624 Methods of preparing amplified nucleic acid molecules |
| 07/10/2003 | US20030129622 Biosensor |
| 07/10/2003 | US20030129621 Performing PCR using a primer pair of a specific combination of nucleic acid primers each comprising specific nucleotide sequence to detect and identify e.g., Aclicyclobacillus, in a sample such as a beverage |
| 07/10/2003 | US20030129620 Genomic DNA is chemically converted with a reagent, 5-methylcytosine and cytosine reacting differently; amplification with polymerase and primer; hybridization to form a duplex; elongation by at least one labeled nucleotide |
| 07/10/2003 | US20030129619 Predicting the epidemic character of a Mycobacterium tuberculosis isolate and/or a selective advantage to be maintained in the host and/or the acquisition of multiple drug resistance (MDR) by the isolate |
| 07/10/2003 | US20030129618 Sensitive and rapid detection of pathogenic organisms and toxins using fluorescent polymeric lipids |
| 07/10/2003 | US20030129617 Calculating a biological characteristic property of a molecule by correlation analysis |
| 07/10/2003 | US20030129616 For predicting physiological and pathophysiological processes in the human body |
| 07/10/2003 | US20030129614 Providing a porous support that deactivates a nucleic acid amplification inhibitor and directing a fluid through the porous support to separate out the nucleic acid component |
| 07/10/2003 | US20030129613 SECX polynucleotides and the membrane-associated or secreted polypeptides encoded by them |
| 07/10/2003 | US20030129611 Provided on hairpin stem- loop molecular beacon probes that hybridize sufficiently near each other on a subject nucleic acid, e.g. mRNA, to generate an observable interaction; lanthanide chelate luminescent resonance energy transfer |
| 07/10/2003 | US20030129610 New QTL's on chromosomes X, 2, 6 and 7 of pigs |
| 07/10/2003 | US20030129609 Assaying for the presence of a genotype characterized by a polymorphism in the NRAMP1 gene. |
| 07/10/2003 | US20030129608 Non-alloying core shell nanoparticles |
| 07/10/2003 | US20030129607 Compositions and methods for extension of nucleic acids |
| 07/10/2003 | US20030129606 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases |
| 07/10/2003 | US20030129604 Identification of molecular sequence signatures and methods involving the same |
| 07/10/2003 | US20030129603 Isolating a collection of polynucleotide sequences corresponding to accessible regions of cellular chromatin |
| 07/10/2003 | US20030129602 High-throughput methods for detecting DNA methylation |
| 07/10/2003 | US20030129601 Selecting the sequences encoding essential molecules as regulatory nucleotidic sequences and proteins for the survival or the virulence of mycobacterium species |
| 07/10/2003 | US20030129600 Probes specific for five different species of Aspergillus, three of Fusarium, four of Mucor, two of Penecillium, five of Rhizopus, and one of Rhizomucor, Absidia, Cunninghamella, Pseudallescheria and Sporothrix |
| 07/10/2003 | US20030129598 Methods for detection of differences in nucleic acids |
| 07/10/2003 | US20030129597 Inhibiting EG-1 to inhibit angiogenesis and metastasis |
| 07/10/2003 | US20030129596 Chemical compounds |
| 07/10/2003 | US20030129595 Mutations associated with iron disorders |
| 07/10/2003 | US20030129594 Genes and the physics of the DNA double-helix. formulation of a physics-based gene identification (PBGI) method: ab initio identification of genes in eukaryotic genomes |
| 07/10/2003 | US20030129592 Identification and characterization of extracellular polypeptides having homology to EGF |
| 07/10/2003 | US20030129589 Dna diagnostics based on mass spectrometry |
| 07/10/2003 | US20030129588 Methods and reagents to detect and characterize norwalk and related viruses |
| 07/10/2003 | US20030129585 Detection of human papillomaviruses |
| 07/10/2003 | US20030129583 Testing for the ability of a stealth virus to induce the production of auto-fluorescent material in cells; destroying suspected stealth virus infected cells in a blood sample |
| 07/10/2003 | US20030129580 Determination of biological characteristics of embryos fertilized in vitro by assaying for bioactive lipids in culture media |
| 07/10/2003 | US20030129202 Mutated hepatitis b virus, its nucleic and protein constituents and uses thereof |
| 07/10/2003 | US20030129200 Inoculation using polymerases that have been deactivated using ultraviolet radiation or enzyme inhibitors such as azido dipyrodiazepinona and/or N-(4-chloro-3-(3-methyl-2-butenyloxy) phenyl)-2-methyl-3-furanocarbothiamide |
| 07/10/2003 | US20030129186 Compositions and methods for modulating blood-brain barrier transport |
| 07/10/2003 | US20030129176 Atherosclerosis-associated genes |
| 07/10/2003 | US20030129171 Cloning mastitis gene; muscular disorders |
| 07/10/2003 | US20030129170 Central nervous system disorders; antidiabetic agents |
| 07/10/2003 | US20030129129 Prevention, therapy disease; forming tritiated water; calibration |
| 07/10/2003 | US20030127621 Kinesin motor modulators derived from the marine sponge adocia |
| 07/10/2003 | CA2473788A1 New tumour markers and biological applications thereof |
| 07/10/2003 | CA2471920A1 Improved structured-functional bonding matrices for biomolecules |
| 07/10/2003 | CA2471658A1 Probe medium and method for fixing probe on a substrate |
| 07/10/2003 | CA2471601A1 Highly sensitive and continuous protein-tyrosine-phosphatase (ptpase) test using 6,8 difluoro-4-methyl-umbelliferylphosphate |
| 07/10/2003 | CA2471452A1 Optineurin and glaucoma |
| 07/10/2003 | CA2471346A1 Method for protein expression analysis |
| 07/10/2003 | CA2471306A1 Secreted proteins |
| 07/10/2003 | CA2471297A1 Human netrin receptor and uses thereof |
| 07/10/2003 | CA2471130A1 Il-17 like molecules and uses thereof |
| 07/10/2003 | CA2471109A1 Enzymatic redox labelling of nucleic acids |
| 07/10/2003 | CA2471090A1 Improvements in and relating to interpreting dna |
| 07/10/2003 | CA2470903A1 A system for stable expression of sirnas in mammalian cells |
| 07/10/2003 | CA2470902A1 Non- or minimally invasive monitoring methods |
| 07/10/2003 | CA2470781A1 Cystine-knot fold protein |
| 07/10/2003 | CA2470707A1 Cellular compositions and methods of making and using them |
| 07/10/2003 | CA2470666A1 Secreted protein |
| 07/10/2003 | CA2469690A1 Beta-amyloid binding factors and inhibitors thereof |
| 07/10/2003 | CA2466861A1 Sensitive coded detection systems |
| 07/10/2003 | CA2465300A1 Method for determining molecule-molecule interaction in proteomics |
| 07/10/2003 | CA2463143A1 Bone morphogenic proteins (bmp), bmp receptors and bmp binding proteins and their use in the diagnosis and treatment of glaucoma |
| 07/10/2003 | CA2458795A1 Improved methods for determining binding affinities |
| 07/10/2003 | CA2458751A1 Compositions and methods for the treatement of immune related diseases |
| 07/09/2003 | EP1325963A1 Method for non-invasive diagnosis of transplantations and transfusions |
| 07/09/2003 | EP1325962A1 A method for determining the biological activity of defibrotide |
| 07/09/2003 | EP1325958A1 Genetic sequence coding for creatinine deiminase, and its use |
| 07/09/2003 | EP1325954A1 An inhibitor of arthropod chitin synthase |
| 07/09/2003 | EP1325927A2 Synthesis of oligonucleotides |
| 07/09/2003 | EP1325776A1 Semiconductor device for detecting organic molecules and method for measuring organic molecules using the same |
| 07/09/2003 | EP1325459A1 High throughput processing system and method of using |
| 07/09/2003 | EP1325457A1 Information rich libraries |
| 07/09/2003 | EP1325338A2 Diagnosis and treatment of alzheimer's disease |
| 07/09/2003 | EP1325335A2 Methods for diagnosing and treating huntington's disease |
| 07/09/2003 | EP1325332A2 Magnetic in situ dilution |
| 07/09/2003 | EP1325300A1 ENHANCEMENT OF i IN SITU /i HYBRIDIZATION |